INTH-454

N/A

Report date: 2023/06/20 09:10:14
NME

Base Information

Drug NameINTH-454
Drug Alias NameINTH-454
ClassificationSmall molecules
Mechanisms of ActioncAMP-response element binding protein inhibitorsHistone acetyltransferase p300 inhibitors
TargetscAMP-response element binding proteinHistone acetyltransferase p300
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInthera Bioscience AG
China Registration ClassN/A

Develop Information

Active CompaniesInthera Bioscience AG
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A